Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ELOVL1 |
| Upstream (Parents) |
|---|
| (<<) CFL1 → ELOVL1 |
| (<<) CRK → ELOVL1 |
| (<<) CYB5R3 → ELOVL1 |
| (<<) EIF6 → ELOVL1 |
| (<<) HSPA8 → ELOVL1 |
| (<<) HSPB1 → ELOVL1 |
| (<<) MAPKAP1 → ELOVL1 |
| (<<) MAT2A → ELOVL1 |
| (<<) MLX → ELOVL1 |
| (<<) RARG → ELOVL1 |
| (<<) RCAN1 → ELOVL1 |
| (<<) RHOA → ELOVL1 |
| (<<) RHOC → ELOVL1 |
| (<<) RYK → ELOVL1 |
| (<<) SHC1 → ELOVL1 |
| (<<) SIN3A → ELOVL1 |
| (<<) TAGLN2 → ELOVL1 |
| Downstream (Children) |
|---|
| ELOVL1 → BCL6 (>>) |
| ELOVL1 → CDK5 (>>) |
| ELOVL1 → CSTB (>>) |
| ELOVL1 → DPH2 (>>) |
| ELOVL1 → GALK1 (>>) |
| ELOVL1 → GSTK1 (>>) |
| ELOVL1 → ID1 (>>) |
| ELOVL1 → KLF6 (>>) |
| ELOVL1 → NUPR1 (>>) |
| ELOVL1 → PPP3CB (>>) |
| ELOVL1 → RDX (>>) |
| ELOVL1 → RHOD (>>) |
| ELOVL1 → SALL2 (>>) |
| ELOVL1 → SLPI (>>) |
| ELOVL1 → STK16 (>>) |
| ELOVL1 → SYK (>>) |
| ELOVL1 → TSPO (>>) |
| ELOVL1 → YRDC (>>) |
